Romano Steven J.
CIK 0001639860
EVP and Chief R&D OfficerDirector
Filings
6
Latest May 22, 2026
Issuers covered
3
Showing
6 of 6
Page 1
Track record
Realized signed returns on open-market buys and sales
No scored trades yet for Romano Steven J.. Track record appears once open-market purchases or sales reach the +30 day horizon.
Issuers
Companies where Romano Steven J. has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| DNTH | Dianthus Therapeutics, Inc. /De/ | 3 | May 22, 2026 |
| SLN | Silence Therapeutics PLC | 2 | Jan 6, 2026 |
| - | Keenova Therapeutics PLC | 1 | Jun 21, 2022 |
All filings
6 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|